{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Medicago", "query": { "sponsor": "Medicago" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-25T23:09:04.365Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03739112", "title": "Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Virus Diseases", "RNA Virus Infections", "Respiratory Tract Diseases", "Respiratory Tract Infections" ], "interventions": [ { "name": "Quadrivalent VLP Vaccine", "type": "BIOLOGICAL" }, { "name": "Fluarix Quadrivalent® Comparator Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 12794, "start_date": "2018-09-18", "completion_date": "2019-07-16", "has_results": true, "last_update_posted_date": "2023-06-23", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 50, "location_summary": "Mobile, Alabama • Tempe, Arizona • Banning, California + 42 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Banning", "state": "California" }, { "city": "Redding", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03739112" }, { "nct_id": "NCT02233816", "title": "Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Virus Diseases", "RNA Virus Infections", "Respiratory Tract Diseases", "Respiratory Tract Infections" ], "interventions": [ { "name": "Low dose of quadrivalent VLP vaccine", "type": "BIOLOGICAL" }, { "name": "Medium dose of quadrivalent VLP vaccine", "type": "BIOLOGICAL" }, { "name": "High dose of quadrivalent VLP vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 300, "start_date": "2014-07-28", "completion_date": "2015-06-22", "has_results": false, "last_update_posted_date": "2019-11-13", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 2, "location_summary": "Hollywood, Florida • Miami, Florida", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02233816" }, { "nct_id": "NCT04636697", "title": "Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "SARS-CoV-2 Infection" ], "interventions": [ { "name": "Intramuscular injection", "type": "DRUG" }, { "name": "Intramuscular vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30918, "start_date": "2020-11-19", "completion_date": "2022-04-30", "has_results": false, "last_update_posted_date": "2022-04-06", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 45, "location_summary": "Birmingham, Alabama • Tempe, Arizona • Canoga Park, California + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04636697" }, { "nct_id": "NCT02768805", "title": "Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Virus Diseases", "RNA Virus Infections", "Respiratory Tract Diseases", "Respiratory Tract Infections" ], "interventions": [ { "name": "15 µg/strain of Quadrivalent VLP Vaccine", "type": "BIOLOGICAL" }, { "name": "30 µg/strain of Quadrivalent VLP Vaccine", "type": "BIOLOGICAL" }, { "name": "15 µg/strain of the licensed quadrivalent vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 900, "start_date": "2016-03-02", "completion_date": "2016-11-26", "has_results": false, "last_update_posted_date": "2020-06-11", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 3, "location_summary": "Hollywood, Florida • South Miami, Florida • Endwell, New York", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Endwell", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02768805" }, { "nct_id": "NCT01991587", "title": "Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Virus Diseases", "RNA Virus Infections", "Respiratory Tract Diseases", "Respiratory Tract Infections" ], "interventions": [ { "name": "Low dose of quadrivalent VLP vaccine", "type": "BIOLOGICAL" }, { "name": "Medium dose of quadrivalent VLP vaccine", "type": "BIOLOGICAL" }, { "name": "High dose of quadrivalent VLP vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 120, "start_date": "2013-10-08", "completion_date": "2014-06-30", "has_results": false, "last_update_posted_date": "2020-06-11", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01991587" }, { "nct_id": "NCT03301051", "title": "Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Virus Diseases", "RNA Virus Infections", "Respiratory Tract Diseases", "Respiratory Tract Infections", "Influenza" ], "interventions": [ { "name": "Quadrivalent VLP Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 10160, "start_date": "2017-08-31", "completion_date": "2018-05-09", "has_results": true, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 29, "location_summary": "Mobile, Alabama • Anaheim, California • Milford, Connecticut + 23 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Milford", "state": "Connecticut" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03301051" }, { "nct_id": "NCT04622592", "title": "Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Instramuscular vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 209, "start_date": "2020-11-02", "completion_date": "2022-04-26", "has_results": true, "last_update_posted_date": "2023-07-21", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 14, "location_summary": "Huntsville, Alabama • Chandler, Arizona • San Diego, California + 11 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04622592" }, { "nct_id": "NCT01657929", "title": "H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza A Subtype H5N1 Infection" ], "interventions": [ { "name": "H5-VLP + GLA-AF", "type": "BIOLOGICAL" }, { "name": "H5-VLP alone", "type": "BIOLOGICAL" }, { "name": "H5-VLP + Alhydrogel(R)", "type": "BIOLOGICAL" }, { "name": "Licensed H5N1 vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Access to Advanced Health Institute (AAHI)", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 105, "start_date": "2012-09", "completion_date": "2014-01", "has_results": false, "last_update_posted_date": "2014-02-26", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 3, "location_summary": "Daytona Beach, Florida • Dallas, Texas • Madison, Wisconsin", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Dallas", "state": "Texas" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01657929" }, { "nct_id": "NCT02831751", "title": "Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Virus Diseases", "RNA Virus Infections", "Respiratory Tract Diseases", "Respiratory Tract Infections" ], "interventions": [ { "name": "30 µg/strain of Quadrivalent VLP Vaccine", "type": "BIOLOGICAL" }, { "name": "60 µg/strain of Quadrivalent VLP Vaccine", "type": "BIOLOGICAL" }, { "name": "FluLaval® Tetra (15 µg/strain)", "type": "BIOLOGICAL" }, { "name": "Fluzone® High-Dose (60 µg/strain)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 1001, "start_date": "2016-04", "completion_date": "2017-01", "has_results": false, "last_update_posted_date": "2019-10-25", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 6, "location_summary": "Redding, California • Hollywood, Florida • South Miami, Florida + 3 more", "locations": [ { "city": "Redding", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT02831751" }, { "nct_id": "NCT01302990", "title": "Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Flu" ], "interventions": [ { "name": "Dose given at Day 0", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Medicago", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 100, "start_date": "2011-02", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2013-08-16", "last_synced_at": "2026-09-25T23:09:04.365Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01302990" } ] }